genisphere.com
GENISPHERE NEWS


The Buzz of BIO contest recognizes the most innovative companies at the 2018 BIO International Convention. Genisphere is pleased to be nominated 
in the Technologies of Tomorrow category.  Vote for us to show your support of the 3DNA nanotechnology platform for targeted drug delivery.   View all nominees and cast your vote here.  See you at the BIO convention!


Technologies of Tomorrow

Genisphere is developing and commercializing 3DNA, the world's first drug delivery nanocarrier built entirely from synthetic DNA. 3DNA combines potent payloads and exquisite targeting molecules to raise therapeutic index of drugs used to treat cancer, cataracts, brain diseases and more.
 
3 reasons to vote for us:
1.  3DNA is biocompatible, cost-effective and fully customizable to either evade or liaise with the body's immune system
2.  Truly accurate tissue specificity allows the use of more potent drugs with otherwise debilitating toxicity
3. We passionately pursue our 3DNA structures as effective drug-delivery nanovehicles for fighting disease